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Otitis media with effusion (OME) is a biofilm driven disease and commonly accepted
otopathogens, such as Haemophilus influenzae, Streptococcus pneumonia, and
Moraxella catarrhalis, have been demonstrated to form polymicrobial biofilms within the
middle ear cleft. However, Alloiococcus otitidis (A. otitidis), which is one of the most
commonly found bacteria within middle ear aspirates of children with OME, has not
been described to form biofilms. The aim of this study was to investigate whether
A. otitidis can form biofilms and investigate the impact on antibiotic susceptibility and
survivability in polymicrobial biofilms with H. influenzae in vitro. The ability of A. otitidis
to form single-species and polymicrobial biofilms with H. influenzae was explored.
Clinical and commercial strains of A. otitidis and H. influenzae were incubated in brain
heart infusion with and without supplementation. Biofilm was imaged using confocal
laser scanning microscopy and scanning electron microscopy. Quantification of biofilm
biomass and viable bacterial number was assessed using crystal violet assays and
viable cell counting in both optimal growth conditions and in adverse growth conditions
(depleted media and sub-optimal growth temperature). Antimicrobial susceptibility and
changes in antibiotic resistance of single-species and multi-species co-culture were
assessed using a microdilution method to assess minimal bactericidal concentration and
E-test for amoxicillin and ciprofloxacin. A. otitidis formed single-species and polymicrobial
biofilms with H. influenzae. Additionally, whilst strain dependent, combinations of
polymicrobial biofilms decreased antimicrobial susceptibility, albeit a small magnitude, in
both planktonic and polymicrobial biofilms. Moreover, A. otitidis promoted H. influenzae
survival by increasing biofilm production in depleted media and at suboptimal growth
temperature. Our findings suggest that A. otitidis may play an indirect pathogenic role in
otitis media by altering H. influenzae antibiotic susceptibility and enhancing growth under
adverse conditions.
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INTRODUCTION
Since the identification of biofilms within the middle ear of
children with chronic otitis media with effusion (OME), OME
has been considered a biofilm driven disease (Hall-Stoodley
et al., 2006; Thornton et al., 2011). The formation of biofilms is
significant, as bacteria within biofilms are conferred protection
from environmental, host and chemical stressors, and have an
increased antibiotic resistance (Donlan and Costerton, 2002;
Fergie et al., 2004). Moreover, bacteria in polymicrobial biofilms
have been shown to further reinforce this protection through
quorum sensing and the transfer of antibiotic resistance genes
between strains (Hackman and Wilkins, 1975; Brook, 1991;
Brook and Gilmore, 1993; Armbruster et al., 2010).
Bacteria, classically associated as otopathogens, such as
Haemophilus influenzae, Streptococcus pneumoniae, and
Moraxella catarrhalis, have all been demonstrated to form
polymicrobial biofilms within the middle ear cleft (Hall-Stoodley
et al., 2006; Thornton et al., 2011). However, there remain
biofilm forming bacteria within the middle ear that have yet to
be identified (Thornton et al., 2011). One such bacterial species
that may potentially be forming biofilms within the middle ear
is A. otitidis. A. otitidis has frequently been reported as one
of the most common bacteria within middle ear aspirates of
patients with OME (Chan et al., 2016, 2017). Yet, the potential of
A. otitidis to form biofilms has yet to be investigated.
In the past,A. otitidis had been considered to be commensal of
the external auditory canal, yet literature suggests that A. otitidis
may have pathogenic potential. In vivo studies have shown
A. otitidis to have an immune-stimulatory potential on both
myeloid (Himi et al., 2000) and lymphoid (Tarkkanen et al., 2000)
cell types and has also been shown to induce OME in a rat model
(Tano et al., 2008).
The aim of this study was to investigate whether A. otitidis
formed biofilms and additionally, whether A. otitidis forms
polymicrobial biofilms with H. influenzae, the most commonly
associated bacterial cause of otitis media. Moreover, the effect
of polymicrobial biofilms of these two bacteria on antibiotic
susceptibility and survival was investigated.
MATERIALS AND METHODS
Bacterial Strains and Handling
A. otitidis ATCC 51267 and H. influenzae ATCC 33391 type
strains were purchased from the American Type Culture
Collection (ATCC). Also, two clinical non-typeableH. influenzae
strains designated NT176 and NT1159, both from middle ear
isolates, were obtained from the Department of Molecular and
Cellular Biology at the University of Adelaide. A. otitidis was
subcultured from freezer stocks onto Brain Heart Infusion
agar supplemented with 5% defibrinated sheep blood (BHIb)
and incubated for 4 days at 37◦C at normal atmospheric
conditions. H. influenzae strains were subcultured in BHI agar
supplemented with 10 µg/mL hemin (factor X) and 0.2 µg/mL
of β-nicotinamide-adenine-dinucleotide (factor V) (BHIs) and
incubated overnight at 37◦C in 5% CO2. All experiments
described below were replicated in biological triplicate.
Planktonic Growth Assays
Bacterial colonies were collected from subcultured bacteria (as
described above) with a sterile swab and added to 2 mL of 0.45%
sodium chloride. This mixture was adjusted to achieve a bacterial
suspension with a McFarland unit of 3.0 for A. otitidis and
McFarland unit of 1.0 forH. influenzae. The bacterial suspension
was combined with BHIs or BHIb respectively to a ratio of 1:14
(bacterial solution: media). This was equivalent to a starting
suspension of 2.0 × 107 single colony forming units per mL
(SCFU/mL) of A. otitidis, 1.4 × 108 SCFU/mL of ATCC 33391,
4.2 × 107 SCFU/mL of NT 176, and 4.8 × 107 SCFU/mL of
NT 1159. The combination of A. otitidis alone, H. influenzae
alone and in combination were made up 1:1 in BHIs up to
10 mL (5 mL each suspension) and incubated for 24 h. Single
colony forming unit (SCFU) assays were used to enumerated
viable cell count at 1, 2, 4, 6, 12, and 24 h to determine growth
characteristics.
Determination of Selective Plates
The requirement of factor V and X for H. influenzae growth
is well documented (Musher, 1996); therefore BHI with 5%
sheep’s blood was used as a selective medium for A. otitidis with
enumeration at 72 h. H. influenzae was enumerated on BHIs
agar plates after 24 h after initial testing showed no growth of
A. otitidis after this time.
Establishing Biofilm
One hundred and eighty microliters of bacterial mixture
(A. otitidis alone, H. influenzae alone and in combination)
were made up 1:1 in BHIs (i.e., 90 µL of each bacterial
strain suspension), was transferred into each of the wells of a
96 (round) well polystyrene microtitre plate (Grenier Cellstar,
Frickenhausen). Control wells contained 90 µL A. otitidis with
90 µL of BHIs, 90 µL H. influenzae with 90 µL of BHIs or BHIs
alone. The 96 well plates were then incubated for 24 h in 5% CO2
(3.5 L Oxoid Anaerobic gas jar with Oxoid CO2 Gen Sachets,
Thermo Scientific, Scoresby, Victoria) at 37◦C on a gyro-shaker
at 70 rpm.
To assess biofilm formation in depleted media, biofilm assays
above were repeated in either BHI only, BHI with factor X only,
and BHI with factor V only. Furthermore, culture at 30◦C with
BHIs was also performed.
Quantifying Biofilm
Biofilm was quantified for each combination of bacteria by two
means; crystal violet staining for biofilm volume, and SCFU
counting for viable bacterial enumeration.
Crystal Violet Assay
Following biofilm formation in the 96-well plates after 24
h, each well was washed twice in Phosphate buffered saline
(PBS) to remove non-adherent cells. Two hundred microliters
of 100% methanol was added to each well and incubated at
room temperature for 15 min. The methanol was suctioned
and wells were allowed to air dry. Two hundred microliters
of crystal violet 10%w/w was added to each well and
incubated at room temperature for 15 min and allowed to
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dry overnight. Two hundred and ten microliters of 95%
ethanol (w/w) was then added to the wells and incubated
at 37◦C for 1 h to extract the crystal violet for biofilm
quantification. Optical density was read at 595 nm using a plate
reader instrument (BMG Labtech, Fluostar Optima, Offenburg,
Germany).
Colony Forming Unit Assay
After formation of biofilm in the 96-well plates after 24 h, each
well was washed twice in PBS. Cells were re-suspended in 100 µL
of PBS by sonicating in a sonicator bath (Soniclean 80T, Soniclean
Pty Ltd., Australia) for 10 min, followed by pipetting up and
down. Bacteria were enumerated on selective plates as described
above.
Biofilm Imaging
Confocal Laser Scanning Microscopy
Biofilms were formed on eight chamber glass slides by adding
300 µL of bacterial suspension (A. otitidis alone, H. influenzae
alone and in combination 1:1) and incubated for 24 h in 5% CO2
at 37◦C on a gyro-shaker at 70 rpm. The slides were washed
thrice in PBS and were prepared for confocal laser scanning
microscopy (CLSM) (Richter et al., 2016). Briefly, biofilms were
fixed with 2.5% glutaraldehyde, then stained with SYTO 9 (1
µL/mL) and propidium iodide (1 µL/mL) in PBS (Live/Dead R©
BaclightTM bacterial viability kit, Thermo Fischer Scientific, Inc.,
Waltham, MA, USA). The slides were examined on a Zeiss
LSM700 Confocal Laser Scanning Microscope (Carl Zeiss, Jena,
Germany).
Scanning Electron Microscopy
Biofilms in the combinations described above (A. otitidis alone,
H. influenzae alone and in combination) were grown for 168 h
on pegs in the Calgary Biofilm Device (Innovotech, Edmonton,
Canada) in BHIs (for H. influenzae and in combination with
A. otitidis), and BHIb (A. otitidis alone), with media replaced
every 24 h. Pegs were washed with PBS, fixed with 2.5%
glutaraldehyde and exposed to 1% osmium tetroxide, followed
by a dehydration series ranging from 50 to 100% ethanol. The
final dehydration step was repeated twice before addition of
hexamethyldisilazane to dry and preserve the biofilm structure.
Biofilms on pegs were then sputter-coated with 5 nm gold and
visualized by scanning electron microscopy (Zeiss Gemini 2, Carl
Zeiss, Jena, Germany).
Antibiotic Susceptibility Testing
Breakpoints were determined as per EUCAST 2016 guidelines
(EUCAST, 2016) and were classified as susceptible (S) or resistant
(R) as follows for H. influenzae: amoxicillin S ≤ 2 µg/mL, R > 2
µg/mL, ciprofloxacin S ≤ 0.5 µg/mL, R > 0.5 µg/mL. Antibiotic
minimum inhibitory concentration (MIC) breakpoints have
not been defined for A. otitidis. Therefore, guidelines for S.
pneumoniae were used to interpret the results as previously
reported (Ashhurst-Smith et al., 2007): amoxicillin S ≤ 0.06
µg/mL, R ≥ 2 µg/mL, ciprofloxacin S ≤ 0.125 µg/mL, R ≥ 2
µg/mL.
Minimum Bactericidal Concentration of
Biofilm
Modified minimum bactericidal concentration assays were
performed in the same combinations as above (Wiegand et al.,
2008). Fifty microliters of H. influenzae alone, A. otitidis alone,
or H. influenzae and A. otitidis together were added to 96-
well plates in BHIs and incubated at 37◦C in 5% CO2 for
24 h. Wells were washed twice in PBS. Serial dilutions of
amoxicillin and ciprofloxacin were made up in BHIs, and
100 µL was added to the wells. The plates were incubated
for an additional 24 h, and bacteria were enumerated via
SCFU counting to establish minimal bactericidal concentrations
(MBC).
Further, antibiotic testing was carried out by E-Test R©
(bioMérieux, SA, Marcy l’Etoile, France) with the above
combinations of H. influenzae and A. otitidis. BHIb agar was
utilized for testing of A. otitidis alone, and BHIs was used
for testing of H. influenzae and when H. influenzae was
in combination with A. otitidis. One milliliter of bacterial
suspension in 0.45% normal saline (McFarland standard of 1.0
and 3.0 for H. influenzae and A. otitidis respectively) was added
to 30 mL of agar. Plates were incubated in 5%CO2 for 24 h
when testing H. influenzae susceptibility and 96 h for A. otitidis.
Susceptibility to ciprofloxacin and amoxicillin was tested.
Statistical Analysis
Pearson’s GraphPad v6 (GraphPad Software Inc., California,
USA) was used to analyze the data, generate box plots and
calculate the statistical tests used. Student’s t-test (two-tailed,
unequal variance) was used to analyze the significance of
differences between single colony unit counts and optical
densities of biofilm cultures. Data with a p-value of 0.05 or less
were considered statistically significant.
RESULTS
A. otitidis Planktonic Growth and Biofilm
Formation
A. otitidis grew both in BHIb and BHIs, with peak growth at 24 h.
Single colonies achieved a stable size by day 4 in both media but
were larger when grown in BHIb. There were a greater number of
viable cells in BHIb than in BHIs at 12 h (BHIb, Mean SCFU/mL
[SD] = 7.7 × 106, [3.1 × 106] vs. BHIs, 1.0 × 106 [7.5 × 105],
p = 0.02), 24 h (BHIb, 6.7 × 107 [1.2 × 107] vs. BHIs, 9.0 × 106
[1.0× 106], p= 0.001), and 48 h (BHIb, 3.2× 107 [1.6× 107] vs.
BHIs, 5.6 × 106 [5.7 × 105], p = 0.046) (Supplementary Figure
1). There was no difference in growth when incubated at normal
atmosphere or in 5% CO2.
CLSM with LIVE/DEAD Baclight bacterial viability stains
indicated that when grown in BHIb, A. otitidis formed
dense, satellite-aggregations of cells with extracellular matrix,
consistent with biofilm (Figure 1A). When grown in BHIs,
cells appeared more dispersed, and aggregations were smaller
in size (Figure 1B). Peak viability of cells and biofilm biomass
assessed with SCFU and crystal violet assay occurred at 48 h of
incubation.
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Co-culture of H. influenzae and A. otitidis
and Formation of Polymicrobial Biofilm
As expected, H. influenzae required factors V and X to grow
(Evans et al., 1974) and did not grow in BHIb. In co-culture in
BHIs, there was no significant change in the number of viable
cells or optical density of the broth, of co-cultured H. influenzae
and A. otitidis compared to single-species controls in the first 48
h of growth.
All three strains of H. influenzae formed biofilm in BHIs.
When co-cultured with A. otitidis in BHIs, polymicrobial
biofilm was observed with all three strains (Figure 2). The
aggregates of A. otitidis biofilm formed in polymicrobial biofilm
were reminiscent of those demonstrated when A. otitidis was
cultured alone in BHIb. A. otitidis biofilm (Figure 3A) and
polymicrobial biofilms (Figure 3B) were visualized by scanning
electron microscopy, where clusters of A. otitidis were observed
next to H. influenzae biofilm.
The number of viable H. influenzae cells via SCFU counting
was similar from mono- or co-cultured biofilm in BHIs.
Additionally, total biofilm biomass, as reflected in the results
FIGURE 1 | Confocal laser scanning microscopy of A. otitidis. Confocal laser
scanning microscopy (CLSM) of dense satellite-aggregations of A. otitidis in
BHIb (A) and sparser aggregations in BHIs (B) at X63 magnification.
Live/Dead Baclight Bacterial Viability staining was used: live cells (with intact
cell membranes) stain green and dead or dying cells (with compromised cell
membranes) stain red.
of the crystal violet assays and SCFU counts, was similar for
co-culture with all threeH. influenzae strains (Table 1, Figure 4).
In contrast, when H. influenzae was cultured in suboptimal
conditions (i.e. BHI in the absence of factor V or X or growth
at 30◦C), the addition of A. otitidis increased the total number
of viable H. influenzae cells and the total biofilm biomass.
No biofilm was demonstrated at 24 h in BHI only, for either
H. influenzae only, H. influenzae with A. otitidis or A. otitidis
only. However, when H. influenzae ATCC 33391 was grown in
BHI with Factor V (Hemin) and Factor X (NAD), there was
a significant increase in optical density for co-cultured biofilm
(0.01 vs. 0.08, 95% CI 0.05 to 0.13, p < 0.001 and 0.22 vs. 0.34,
95% CI 0.06 to 0.18, p < 0.001 respectively) (Figures 5, 6) and
viable cell count (Table 1). Similar results were demonstrated for
viable cell count (Table 1) and optical density of NT 1159 biofilm
(0.001 vs. 0.04, 95% CI 0.01 to 0.08, p = 0.007 and 0.2 vs. 0.34,
95% CI 0.09 to 0.18, p < 0.001) and likewise for NT 176 biofilm
(0.03 vs. 0.07, 95% CI 0.02 to 0.09, p = 0.19 and 0.04 vs. 0.12,
95% CI 0.06632 to 0.096, p < 0.001) (Figures 5, 6) and viable cell
counts (Table 1).
For culture at 30◦C, there was a significant increase in biofilm
mass demonstrated using the crystal violet assay for the non-
typeableH. influenzae strains NT 176 and NT 1159 (0.34 SD 0.05
FIGURE 3 | Scanning Electron Microscopy (SEM) of A. otitidis and
H. influenzae multispecies biofilm. A. otitidis single species biofilm in BHIb (A)
and multispecies biofilm in BHIs (B) of A. otitidis (cocci, arrows) and
H. influenzae (rods, asterisks).
FIGURE 2 | Confocal laser scanning microscopy of A. otitidis and H. influenzae multispecies biofilm. (A–C) CLSM of multispecies biofilm in BHIs at X63 magnification,
after LIVE/DEAD Baclight Bacterial Viability staining consisting of A. otitidis (Green cocci, arrows) and H. influenzae (mixed, smaller, orange-green coccobacilli,
asterisks). The H. influenzae strains shown are NT 1159 (A), NT 176 (B), and ATCC 33391 (C).
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TABLE 1 | Viable cell counts of Haemophilus influenzae in biofilm when cultured alone or in combination with Alloiococcus otitidis and when cultured in different media.
ATCC 33391 ATCC 33391 + AO P-value NT 1159 NT 1159 + AO P-value NT 176 NT 176 + AO P-value











































Single colony forming unit enumeration on selective plates (BHIs) of the three strains of H. influenzae (ATCC 33391, NT176, and NT 1159) when cultured alone or co-cultured with
A. otitidis (AO). Bacterial combinations were incubated for 24 h in 5% CO2 at 37
◦C on a gyro-shaker. Experiments were conducted in optimal media (BHI+ Factor V and X), and reduced
media (BHI + Factor V only and BHI + Factor X only). ([Mean SCFU/mL (SD)].
FIGURE 4 | Crystal violet assay and viable cell counts of polymicrobial biofilm in BHIs. Quantification of the three H. influenzae (ATCC 33391, NT176, and NT1159)
biofilms, alone and in the presence of A. otitidis (AO), in reduced brain heart infusion supplemented with Factor V and X. Graphs represent crystal violet staining and
absorbance reading at 565 nm (Left) with corresponding SCFU counts (Right). Data are presented as means ± SD for n = 4.
FIGURE 5 | Crystal violet assay and viable cell counts of polymicrobial biofilm in BHI + Hemin. Q Quantification of the three H. influenzae (ATCC 33391, NT176, and
NT1159) biofilms, alone and in the presence of A. otitidis (AO), in reduced brain heart infusion supplemented with Factor X (hemin). Graphs represent crystal violet
staining and absorbance reading at 565 nm (Left) with corresponding SCFU counts (Right). Data are presented as means ± SD for n = 3. *p < 0.05, **p < 0.01.
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FIGURE 6 | Crystal violet assay and viable cell counts of polymicrobial biofilm in BHIs + NAD. Quantification of the three H. influenzae (ATCC 33391, NT176, and
NT1159) biofilms, alone and in the presence of A. otitidis (AO), in reduced brain heart infusion supplemented with Factor V (nicotinamide adenine dinucleotide - NAD).
Graphs represent crystal violet staining and absorbance reading at 565 (Left) with corresponding SCFU counts (Right). Data are presented as means ± SD for n = 3.
**p < 0.01, ***p < 0.001.
FIGURE 7 | Crystal violet assay of polymicrobial biofilm at 30◦C. Quantification of H. influenzae ATCC 33391 (ATCC) (A), NT 176 (B), and NT 1159 (C) biofilm
biomass in the presence or absence of A. otitidis biofilm grown for 24 h at 30◦C in BHIs. Biofilm biomass was measured using crystal violet staining and absorbance
reading at 565 nm. Data are presented as means ± SD for n = 3. ***p < 0.001.
vs. 0.39 SD 0.07, 95% CI 0.03 to 0.08, p < 0.001 and 0.09 SD
0.06 vs. 0.17 SD 0.06 CI 0.05 to 0.11, p < 0.001) when grown in
co-culture with A. otitidis (Figure 7).
Antibiotic Susceptibility
A. otitidis
A. otitidis was found to be susceptible to both amoxicillin and
ciprofloxacin by E-test (0.016 and 0.016 µg/mL respectively)
(Table 2). In co-culture, there was a change in the MIC of
A. otitidis in combination with all 3 strains of H. influenzae, with
a 2.9-fold decrease in susceptibility to amoxicillin (0.016 vs. 0.047
µg/mL).
For ciprofloxacin, when A. otitidis was co-cultured in
combination with H. influenzae strain NT176, the MIC fell from
0.016 to 0.012 µg/mL. H. influenzae strains NT 1159 and ATCC
33391 did not alter the MIC of A. otitidis.
In the microdilution assays, the MBC of A. otitidis for
amoxicillin and ciprofloxacin was 0.125 and 0.25 µg/mL
respectively. With the addition of H. influenzae strain NT 176,
the MBC decreased for both amoxicillin and ciprofloxacin (0.06
and 0.125µg/mL respectively).H. influenzae strains NT 1159 and
ATCC did not influence MBC.
H. influenzae
All three H. influenzae were susceptible to both amoxicillin
and ciprofloxacin (Table 3). Again, co-culture affected the
susceptibility in some combinations. In co-culture with
A. otitidis, there was a relative decrease in the susceptibility
of NT 176 to amoxicillin (MIC = 1.5 vs. 2.0 µg/mL). There
was no change to the MICs of strains ATCC 33391 or NT
1159.
For ciprofloxacin, when in co-culture with A. otitidis, there
was a relative decrease in susceptibility for strains ATCC 33391
(MIC = 0.008 vs. 0.012 µg/mL) and NT 1159 (MIC = 0.008 vs.
0.012 µg/mL). There was no change in MIC for strain NT 176.
DISCUSSION
This is the first study to our knowledge to demonstrate
that A. otitidis forms biofilm in vitro. Additionally, we
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TABLE 2 | Minimum inhibitory concentrations (MIC) and Minimum Bactericidal
Concentration (MBC) for A. otitidis (AO) planktonic cells and biofilm alone and in
combination with H. influenzae (ATCC 33391, NT176, and NT 1159).





A. otitidis (AO) 0.016 (S) 0.125
AO + ATCC 33391 0.047 (S) 0.125
AO + NT 176 0.047 (S) 0.06
AO + NT 1159 0.047 (S) 0.125
CIPROFLOXACIN
AO 0.016 (S) 0.25
AO + ATCC 33391 0.016 (S) 0.25
AO + NT 176 0.012 (S) 0.125
AO + NT 1159 0.016 (S) 0.25
MIC was assessed by E-test with BHIb agar, of A. otitidis monospecies or in co-culture
with H. influenzae (ATCC 33391, NT176, and NT1159 strains). All strains were susceptible
(S) to amoxicillin and ciprofloxacin in planktonic form (MIC ≤ 0.06 µg/mL and S ≤ 0.125
µg/mL respectively). MBC of A. otitidis monospecies or in co-culture with H. influenzae
was determined by SCFU counting.
TABLE 3 | Minimum inhibitory concentrations (MIC) and Minimum Bactericidal
Concentration (MBC) for H. influenzae (HI) (ATCC 33391, NT176, and NT1159
















ATCC 33391 1.0 (S) 1.0 (S) 32 32
NT 176 1.5 (S) 2.0 (S) 32 64
NT 1159 1.0 (S) 1.0 (S) 32 32
CIPROFLOXACIN
ATCC 33391 0.008 (S) 0.012 (S) 0.1 0.1
NT 176 0.012 (S) 0.012 (S) 0.05 0.1
NT 1159 0.008 (S) 0.012 (S) 0.023 0.023
Minimum inhibitory concentrations (MIC) and Minimum bactericidal concentration (MBC)
for H. influenzae (HI) (strains ATCC 33391, NT 176, and NT 1159) in planktonic and biofilm
antibiotic susceptibility respectively. MIC was assessed by E-test method with BHIs agar
of H. influenzae monospecies or in co-culture with A. otitidis. All strains were susceptible
(S) to amoxicillin and ciprofloxacin in planktonic form (MIC ≤ 2 µg/mL and ≤ 0.5 µg/mL
respectively). MBC of H. influenzae monospecies or in co-culture with A. otitidis was
determined by SCFU counting.
demonstrated that A. otitidis and H. influenzae form
polymicrobial biofilms and that once in this form, these
bacteria develop traits that promote bacterial survival and
resistance to treatment.
A. otitidis is the most prevalent bacterial species found in
patients with non-purulent OME (20–40%) (Leskinen et al.,
2004; Guvenc et al., 2010; Marsh et al., 2012; Chan et al.,
2016, 2017). In the past, A. otitidis has been considered a
commensal of the external ear canal (Frank et al., 2003; Tano
et al., 2008). However, consensus on the role ofA. otitidis remains
divided, as A. otitidis has been shown to have pathogenic traits
including eliciting immune responses in vitro (Himi et al., 2000;
Tarkkanen et al., 2000; Harimaya et al., 2005, 2007a,b, 2009),
invading intracellularly (Faden and Dryja, 1989) and having been
identified as a pathogen in device related (Marchino et al., 2013)
and chronic infection (Cakar et al., 2013). Utilizing culture-
independent 16S rRNA sequencing, our department confirmed
that A. otitidis and H. influenzae are the two most common
bacteria demonstrated in children with OME and that the
external ear canal may act as a reservoir for the middle ear (Chan
et al., 2017, 2016). Furthermore, phylogenetic analysis from
these studies demonstrated an inverse relationship in relative
abundance between A. otitidis and H. influenzae, suggesting the
potential for bacterial interaction in these patients.
In showing that A. otitidis forms biofilm, we have added
to the evidence that this species of bacteria may play a role
in the pathogenesis of OME. OME appears to be a biofilm
driven disease and the ability of A. otitidis to form biofilm is
consistent with this perception (Hall-Stoodley et al., 2006). The
life cycle of biofilms closely resembles the natural history of
OME, which is characterized by frequent spontaneous resolution,
but also by high recurrence rates and persistence of bacteria
despite antibiotic treatment. While in biofilm form, the bacteria
may cause low grade subacute inflammation and thus perpetuate
middle ear effusion (Stewart and Costerton, 2001). However,
through planktonic shedding of the biofilm an acute infection
with an associated intense inflammatory response can result.
Additionally, the formation of biofilm has been shown to provide
bacteria a survival and persistence advantage against not only
environmental (e.g., fluctuations in temperature, oxygen tension,
pH) and chemical (e.g., antibiotics) stressors but also against
phagocytosis and humoral immunity (Donlan and Costerton,
2002; Fergie et al., 2004).
In the setting of OM, biofilms were first demonstrated in
the middle ear in an animal model of OM (Post, 2001; Ehrlich
et al., 2002). Since that time, middle ear biofilm has been shown
in patients with chronic suppurative OM, cholesteatoma (Park
et al., 2009), tympanostomy tubes (Wang et al., 2014), and
also free floating within the middle ear aspirates of children
with OME (Van Hoecke et al., 2016). In addition, biofilm has
been demonstrated covering the middle ear mucosa (MEM)
in the majority of children with OME in two separate studies
(Hall-Stoodley et al., 2006; Thornton et al., 2011). Interestingly,
one of these studies (Thornton et al., 2011) noted that “a
significant proportion” of MEM biofilm samples had bacteria
not identifiable by the Fluorescent In Situ Hybridization (FISH)
probes they used. Given that A. otitidis forms biofilm and its high
relative abundance within the middle ear cleft of OME, A. otitidis
may represent a portion of these unidentifiable bacteria. Further
experiments using A. otitidis specific probes will be needed to
confirm this hypothesis.
Another significant finding of this study was that A. otitidis
and H. influenzae co-existed within polymicrobial biofilms. As
discussed above, multispecies biofilm is prevalent within the
middle ear cavities of children with OME and has been associated
with bacterial growth advantage and greater resistance than
in single species biofilms (Armbruster et al., 2010; Weimer
et al., 2010). Consistent with this we found that the presence of
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A. otitidis promoted H. influenzae biofilm growth at suboptimal
growth temperatures and in the absence of critical nutrients
(factors X and V). In the setting of OME, polymicrobial biofilm
formation with A. otitidis may thus result in the persistence
of H. influenzae in biofilm during times of adverse growth
conditions. Yet, when conditions are more conducive to growth,
H. influenzae may then re-emerge in planktonic form and
potentially resulting acute infection.
In addition, whilst single species biofilm formation is known
to provide increased antibiotic resistance (Stewart and Costerton,
2001; Donlan and Costerton, 2002), polymicrobial biofilm is
thought to confer even greater protection from host defenses
and antimicrobials(Hackman and Wilkins, 1975; Brook, 1991;
Brook and Gilmore, 1993; Armbruster et al., 2010). Some
of the recognized mechanisms behind increased resistance in
polymicrobial biofilm includes: increased adaptation via quorum
sensing, upregulation and transfer of antibiotic resistance
genes and increased levels of mutations in antibiotic target
molecules (Høiby et al., 2010). In our study, we found that
antibiotic susceptibility effects were strain specific, and whilst
of small magnitude, resulted in increased antibiotic resistance
of investigated H. influenzae strains in polymicrobial co-
culture. In addition, we propose that the antibiotic effects
demonstrated are β-lactamase independent, given that A. otitidis
has not proven to be a β-lactamase producer (Bosley et al.,
1995).
A limitation of this study was the small number of
bacterial strains investigated, but we believe that these results
highlight an area for potential further research. Whilst only
one strain of A. otitidis was utilized, due to limitations in
obtaining clinical isolates, both commercially available type
strains and clinical strains of H. influenzae were investigated.
Further studies, both in vitro and in vivo, exploring the
ability for the formation of polymicrobial biofilms with
clinical isolates of A. otitidis and their interactions with
H. influenzae and other classically accepted otopathogens, such
as M. catarrhalis and S. pneumoniae, will likely provide further
insight into the role of A. otitidis in the pathogenesis of
OME.
CONCLUSION
In this study, we have described another potential role that
A. otitidis plays in the pathogenesis of OME. We demonstrated
that A. otitidis forms both single- and multi- species biofilm
with H. influenzae. In addition, when in polymicrobial biofilm,
A. otitidis can promote H. influenzae growth and survival by
increasing biofilm production in adverse growth conditions and
by altering antimicrobial resistance.
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